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ess: geddesl@mcmasterSummary The purpose of this study was to conduct a systematic review to
determine the effect of inspiratory muscle training (IMT) on inspiratory muscle
strength and endurance, exercise capacity, dyspnea and quality of life for adults
with chronic obstructive pulmonary disease (COPD).
A systematic review of the literature was conducted according the Cochrane
Collaboration protocol using Medline and CINAHL. Nineteen of 274 extracted articles
met the inclusion criteria and addressed comparisons of interest which included: IMT
versus sham; IMT versus no intervention; low- versus high-intensity IMT; and two
different modes of IMT. Thirteen meta-analyses were reported.
Results indicate that targeted resistive or threshold IMT was associated with
significant improvements in some outcomes of inspiratory muscle strength (PImax (cm
H2O)) and endurance (Inspiratory Threshold Loading (kPa)), exercise capacity (Borg
Scale for Respiratory Effort (modified Borg scale), Work Rate maximum (Watts)), and
dyspnea (Transition Dyspnea Index), whereas IMT without a target or not using
threshold training did not show improvement in these variables. There was no
conclusive evidence regarding quality of life measures.
IMT is effective for adults with COPD when using threshold or targeted devices
that control or provide a target for training intensity.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
5 9140x27813; fax: +905 524 0069.
.ca (E.L. Geddes).
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Chronic obstructive pulmonary disease (COPD) is a
slow, progressive, incurable disease affecting the
airways of the lungs resulting in loss of lung
function1 that places a substantial burden upon
patients, their families and the health care system.
In 1998/1999, 3.2% of Canadians were diagnosed
with COPD while in 2001, 4.4% of Americans
reported having COPD.1,2 The prevalence of COPD
is under-estimated however1,2 since COPD is not
usually diagnosed until symptoms are moderate to
severe in nature.3
Individuals with COPD experience inspiratory
muscle dysfunction due to the combined effects
of increased work of breathing, hyperinflation,
malnutrition, hypoxemia, hypercapnea and possi-
ble use of corticosteriods resulting in decreased
inspiratory muscle strength and endurance.4,5
Functionally, this presents as dyspnea and de-
creased exercise tolerance in individuals with
COPD. Ramı´rez-Sarmiento et al.6 have shown
that inspiratory muscle training (IMT) is asso-
ciated with improvement in inspiratory muscle
strength and endurance, and with structural
changes in the inspiratory muscle fibers. There-
fore, improving inspiratory muscle strength and
endurance is one management strategy that
may help to relieve the sensation of dyspnea,
thereby increasing the level of activity and
improving quality of life for individuals with
COPD.
The early literature on the use of IMT with
individuals with COPD presents a mixed picture but
generally is not supportive of this intervention. A
meta-analysis published by Smith et al.7 concluded
that there was little evidence supporting the use of
IMT in this population. However, the majority of
studies included in this review did not control the
pattern of breathing which could have resulted in a
lower training resistance of IMT and Smith recom-
mended further study. More recently, Lo¨tters et al.8
in 2002 published a second meta-analysis. While
Lo¨tters and colleagues supported the addition of
IMT in pulmonary rehabilitation, this meta-analysis
did not discuss the mode(s) and intensity of IMT
used.
The purpose of this study was to examine
the effects of IMT on inspiratory muscle strength
and endurance, exercise capacity, dyspnea and
quality of life in adults living with COPD.
Specifically, this study compared the effect of:
(1) IMT versus sham IMT; (2) IMT versus no
intervention; (3) low intensity versus high-
intensity IMT; and (4) different types (modes) of
IMT.Methods
A systematic review was conducted according to
methods of the Cochrane Collaboration.9
Search strategy
Medline and CINAHL electronic databases were
searched from their inception up to August 2003.
Reference lists from pertinent articles and books
were searched, personal contact was made with
authors and targeted journals were hand-searched
to identify any relevant articles.
Study criteria
Studies were required to meet the following
inclusion criteria: (i) randomized controlled trial
or randomized cross-over trial; (ii) published in
English; (iii) with adult participants (18 years of age
or older) with a diagnosis of stable COPD; (iv) that
compared IMT to another comparison group. IMT
was defined as any intervention(s) with the purpose
of training the inspiratory muscles. The interven-
tion could be administered in an institutional or
home setting and may or may not have been
supervised.
Defining no intervention
No intervention was defined as a control group that
received standard medical management but had no
IMT of any mode or intensity and no other
intervention, i.e. patient education or breathing
exercises.
Defining sham, low- and high-intensity IMT
In order to standardize across studies that defined
sham IMT and low-intensity IMT at similar percen-
tages of PImax, we defined these loads using the
tidal inspiratory pressure (PI) of individuals with
COPD as reported by Be´gin and Grassino.10 Sham
IMT was defined as that using the same type of
device as the intervention group at an intensity less
than or equal to the mean PI plus one standard
deviation (SD). Since PI is directly proportional to
the partial pressure of carbon dioxide in the
arterial blood (PCO2) of patients with COPD,
10
sham IMT for normocapneic individuals was defined
as any intensity p8.3 cm H2O (i.e. mean PI+1 SD)
and for individuals with moderate hypercapnia, as
any intensity p11.5 cm H2O. Nine studies did not
report the mean PCO2 at baseline.
17,23,24,28–33
Seven of these studies reported sham as no or
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sham/low IMT intensity of 517 and 6.824 cm H2O,
respectively, which is less than our definition for
sham in normcapneic individuals.
When a study included two groups using IMT
where the intensity for both groups was greater
than the mean PI+1 SD, and where there was a clear
difference at the beginning of the study between
the intensity of intervention for both groups based
on the PI, the study was included in the low versus
high subgroup comparison. As a result, the defini-
tions of sham, low- and high-intensity IMT used in
this systematic review may be different from the
original authors’ definitions of sham, low- and high-
intensity IMT.Different types of inspiratory muscle
trainers—defining modes of IMT
Studies were classified into whether the interven-
tion utilized: (i) targeted inspiratory resistive or
threshold trainers; (ii) non-targeted inspiratory
resistance trainers; or (iii) normocapneic hyper-
ventilation trainers.
The threshold or targeted inspiratory resistive
trainers ensure or facilitate attainment of training
intensity during the training session. The Thresh-
olds trainer contains a calibrated spring-loaded
valve that provides a constant, pre-determined
training load that is maintained unless the partici-
pant drastically alters his/her breathing pattern.
Targeted inspiratory resistive trainers incorporate a
visual target for pacing breathing pattern that is
placed inline with the inspiratory resistive trainer
device. The most common target used is an
incentive spirometer (e.g. Respirexs2y) however,
other more complex targets have been utilized.
Non-targeted inspiratory resistance trainers do not
provide a target or means of controlling breathing
pattern to ensure or facilitate the attainment of
the training intensity. The most common commer-
cial devices are the PFlexz and the IMT by DHD.y
Normocapneic or isocapneic hyperventilation or
hyperpnea trainers include a visual target and use a
rebreathing system and oxygen infusion set-up so
that the participant maintains a constant level ofThresholds trainers available from Respironics HealthScan
Inc., 41 Canfield Rd., Cedar Grove, NJ, 07009-1201. 1-800-962-
1266.
yRespirexs2 available from DHD 22-1000, Diemolding Health-
care Division, Canastota, NY, 13032.
zP-Flex resistive trainer available from Respironics HealthScan
Inc., 41 Canfield Rd., Cedar Grove, NJ, 07009-1201. 1-800-962-
1266.
yInspiratory muscle trainer available from DHD Medical
Products, Diemolding Healthcare Division, Canastota, NY 13032.PCO2 and PO2 during hyperventilation. Training
intensity is set at a percentage of the maximum
voluntary ventilation. Because normocapneic hy-
perventilation IMT devices require more equip-
ment, they have primarily been used in research
and are not readily available to clinicians.Study inclusion and data abstraction
All abstracts retrieved from the literature search
were reviewed independently by two reviewers (DB
and KO). If one or both reviewer(s) believed the
study met the inclusion criteria, the entire paper
was independently reviewed by the same two
reviewers to determine whether the study met
the inclusion criteria. If there was any disagree-
ment or uncertainty about including the study in
the review, a third reviewer was asked to assess the
study to determine final inclusion.
For the studies that met the inclusion criteria,
data were abstracted independently by two re-
viewers (KO and LG, KO and JC, or, KO and DR) onto
standard data abstraction forms. Abstracted data
included: study citation, objectives, design, and
duration; times at which participants were as-
sessed; participant inclusion and exclusion criteria;
characteristics of included participants (e.g. age,
gender, severity of COPD); description of the IMT
intervention (i.e. frequency, intensity, progression
of intensity, duration, mode, level of supervision);
description of control or other intervention group;
number of participants at baseline and at study
completion; types of outcomes used and their
values at baseline and at study completion.
The outcome measures assessed for this systema-
tic review included, but were not limited to,
inspiratory muscle strength (e.g. maximum inspira-
tory pressure—PImax, maximum voluntary ventila-
tion), inspiratory muscle endurance (e.g. sustained
inspiratory pressure, inspiratory threshold loading),
exercise capacity (e.g. 6 or 12min walk
tests—6MWT/12MWT, Borg scale for effort), dys-
pnea (e.g. Transition Dyspnea Index—TDI), quality
of life (e.g. Chronic Respiratory Disease Question-
naire—CRQ) and lung volumes and/or spirometry
(e.g. forced vital capacity—FVC, forced expiratory
volume in 1 s—FEV1).
Methodological quality of the studies was also
assessed by two reviewers (DB and KO) for each of
the included studies using the criteria by Jadad et
al.11 for randomization, double-blinding and with-
drawals/drop-outs. In addition, groups were as-
sessed as to whether they were similar at baseline
and whether an intention-to-treat analysis was
performed. Per protocol analysis occurred when
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Figure 1 Flow diagram indicating number of studies
retrieved from the search strategies, and the number of
studies excluded and included in this systematic review.
IMT in adults with COPD: A systematic review 1443only participants who adhered to the research
protocol were analyzed.12,13 A description of the
methodological quality of the studies was com-
pleted rather than generating a formal methodolo-
gical score.9
In instances where there was insufficient data
available in the articles, or further clarification was
required, authors from the original articles were
contacted requesting further information.
Data analysis
Subgroups analyses were performed on targeted
inspiratory resistive or threshold trainers for the
following comparisons: (1) IMT versus sham IMT; (2)
IMT versus no intervention; (3) low-intensity versus
high-intensity IMT; and (4) targeted inspiratory
resistive IMT versus threshold IMT. One further
subgroup comparison included non-targeted in-
spiratory resistive IMT versus sham IMT.
Meta-analyses were performed using the RevMan
Version 4.2.214 software to perform the statistical
analysis. Outcomes were analyzed as continuous
outcomes using the random effects model to
calculate the weighted mean difference and 95%
confidence intervals. Po0:05 was considered sig-
nificant for overall effect and Po0:1 was consid-
ered significant for heterogeneity.15 Sensitivity
analyses were performed in the presence of
significant heterogeneity in which studies were
systematically removed from the analyses to
determine the robustness of the findings. In
instances of statistical heterogeneity, potential
reasons for heterogeneity were discussed and a
rationale was provided for whether combining
studies made practical sense, as suggested by Lau
et al.15 Where no comparisons were possible to
permit a meta-analysis, a qualitative analysis of the
studies was completed.Results
Description of included studies
The search strategy retrieved a total of 274
citations of which 196,16–33 were judged to meet
the inclusion criteria and addressed subgroup
comparisons of interest (Fig. 1). Ten studies
compared targeted inspiratory resistive or thresh-
old IMT versus sham IMT (Table 1). One study
compared targeted inspiratory resistive IMT versus
no intervention, one compared both targeted
inspiratory resistive IMT and threshold IMT versus
no intervention as well as comparing these twomodes of IMT, and one compared low versus high
IMT (Table 2). Six studies compared non-targeted
inspiratory resistive IMT versus sham IMT (Table 3).
Four articles required a third reviewer to deter-
mine final study inclusion and in each case were
deemed to not meet the inclusion criteria.Participants of included studies
Participants in the included studies were adults
with COPD with an average age ranging from 61 to
70 years and an average FEV1 ranging from 24% to
52% predicted. Less than 30% of the study partici-
pants were females.Methodological quality of studies
All 19 included studies were described as rando-
mized, however only 3 described the actual
randomization process.26,27,31
Seven of the 19 included studies were described
as double-blinded in which both participants
and outcome assessors were blind to the interven-
tion and allocation of participants within
groups.19–21,23,24,27,30 Single blinding occurred in
10 of the 19 studies, in which participants were
unaware of the intervention they received due to
the use of sham IMT.6,16–18,22,28,29,31–33 Blinding was
not specified in two of the 19 studies in which IMT
was compared with no intervention.25,26
Twelve of the 19 included studies reported on
participants who withdrew from the study, or were
non-compliant with the intervention. Two of these
12 studies reported no withdrawals,18,29 whereas
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Table 1 Characteristics of studies included in the systematic review: targeted inspiratory resistive IMT or threshold IMT versus sham IMT.
Study Method Sample size
(N ¼ at
baseline;
W ¼ %
withdrawal)
Patient
characteristics
(mean age in
years; % male
upon completion
of study)
Severity of
COPD (FEV1%
predicted or
FEV1/FVC;
mean PCO2 at
baseline)
Mode of IMT and
supervision
Monitoring of
breathing
pattern
Time, intensity
and progression of
IMT
Frequency and
duration of
IMT
Intensity of
sham IMT (cm
H2O)
Outcomes assessed
Belman
et al.16
RT; high versus low
IMT (redefined as
IMT versus sham
for this review)
N ¼ 20,
W ¼ 15:0%
64 years, 59% male FEV1/
FVC ¼ 0.33,
39mmHg
Targeted inspiratory
resistance trainer;
daily log and
supervision once per
week in lab
Controlled at
12.5 breaths
per minute
15min per session
@ a maximum
pressure tolerated
2X per day, 7
days per week
for 6 weeks
7.5–10 Inspiratory muscle
strength, inspiratory
muscle endurance,
exercise capacity,
Pulmonary function
tests/spirometry
Harver
et al.17
RT; IMT versus
sham
N ¼ 23,
W ¼ 17:4%
63 years, 84% male FEV1 38%
predicted,
PCO2 NR
PFlex adapted to give
targeted visual
feedback; Not
supervised. Biweekly
phone calls to home.
Spontaneous
breathing
pattern
15min per session
@ 5–35 cm H2O/l s.
Participants
encouraged to
increase to a new
training level
(PFlex setting)
every 7–10 days
2X per day, 7
days per week
for 8 weeks
5 cmH2O/l s Inspiratory muscle
strength, dyspnea,
Pulmonary function
tests/spirometry
Heijdra
et al.18
RT; high versus low
IMT (redefined as
IMT versus sham
for this review)
N ¼ 20,
W ¼ 0%
62 years, 75% male FEV1 36%
predicted,
45mmHg
Targeted inspiratory
resistance trainer; PT
checked in once per
week with
participants
3 s inspiration,
4 s expiration
monitored by
target of
incentive
spirometry
15min per session
@ 60% PImax,
intensity adjusted
weekly to
maintain PImax of
60%
2X per day, 7
days per week
for 10 weeks
5.7 (10% PImax
at baseline)
Inspiratory muscle
strength, inspiratory
muscle endurance,
Pulmonary function
tests/spirometry
Kim
et al.19
RT; IMT versus
sham
N ¼ 112,
W ¼ 40:2%
65 years, 76% male FEV1 40%
predicted,
42mmHg
Threshold load
trainer; Diary and
nurse called
participants at home
to monitor progress,
provide coaching,
encourage adherence
Noseclips 15–30min per
session @ 30%
PImax. Intensity
increased monthly
to sustain 30%
PImax
1X per day, 7
days per week
for 24 weeks
’’
barely
perceptible
and too light
to influence
strength’’ (p.
358)
Inspiratory muscle
strength, inspiratory
muscle endurance,
Exercise capacity,
Dyspnea
Larson
et al.20
RT; high versus low
IMT (redefined as
IMT versus sham
for this review)
N ¼ 45,
W ¼ 51:1%
63 years, 91% male FEV1 32%
predicted,
41mmHg
Threshold load
trainer; daily log and
telephone call once
per week
NR 15min (week 1),
30min (week 2–8)
@ 30% PImax,
progression of
intensity: NR
1X per day, 7
days per week
for 8 weeks
8 (15% PImax at
baseline)
Inspiratory muscle
strength, inspiratory
muscle endurance,
Exercise capacity,
quality of life
E.L.
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Lisboa
et al.21
RT; high versus low
IMT (redefined as
IMT versus sham
for this review)
N ¼ 20,
W ¼ NR
62 years, 65% male FEV1 38%
predicted,
41mmHg
Threshold load
trainer; Not
supervised
NR 30min per session
@30% PImax.
Intensity adjusted
every week to
ensure PImax
remained at
target level
1X per day, 6
days per week
for 10 weeks
5 (10% PImax at
baseline)
Inspiratory muscle
strength, Exercise
capacity, Dyspnea,
Pulmonary function
tests/spirometry
Patessio
et al.22
RT; IMT versus
sham
N ¼ 16,
W ¼ NR
63 years, 100%
male
FEV1 52%
predicted,
42mmHg
Targeted inspiratory
resistance trainer
(resistance trainer
with visual feedback);
NR
Spontaneous
breathing
pattern
15min per session
@50% PImax,
Progression of
intensity NR
4X per day, 7
days per week
for 8 weeks
No inspiratory
resistance
Inspiratory muscle
strength, inspiratory
muscle endurance,
Dyspnea, Pulmonary
function tests/
spirometry
Sa´nchez-
Riera
et al.23
RT; IMT versus
sham
N ¼ 20,
W ¼ 0%
67 years, 90% male FEV1 40%
predicted,
PCO2 NR
Targeted inspiratory
resistance trainer;
Not supervised
Controlled at 8
breaths per
min with
metronome
15min per session
@30% PImax,
modified every 6
wks to maintain
30% PImax (target
load began at 6 cm
H2O and increased
every 2min by
2 cm H2O)
2X per day, 6
days per week
for 24 weeks
No inspiratory
resistance
Inspiratory muscle
strength, inspiratory
muscle endurance,
exercise capacity,
quality of life,
Dyspnea
Villafranca
et al.24
RT; high versus low
IMT (redefined as
IMT versus sham
for this review)
N ¼ 20,
W ¼ NR
62 years, 65% male FEV1/
FVC ¼ 0.39,
PCO2 NR
Threshold load
trainer; Not
supervised
NR 15min per session
@ 30% PImax.
Intensity adjusted
each week to
ensure PImax
remained at
target level
2X per day, 6
days per week
for 10 weeks
6.8 (10% PImax
at baseline)
Inspiratory muscle
strength, inspiratory
muscle endurance
Ramı´rez-
Sarmiento
et al.6
RT; IMT versus
sham
N ¼ 14,
W ¼ 0%
66 years, 100%
male
FEV1 24%
predicted,
45mmHg
Threshold load
trainer; supervised by
personnel
NR 30min per session
@ 60% maximum
sustained
inspiratory
pressure (SIP).
Intensity adjusted
dependent on
participant
tolerance
1X per day, 5
days per week
for 5 weeks
No inspiratory
resistance
Inspiratory muscle
strength, inspiratory
muscle endurance,
Exercise capacity,
Pulmonary function
tests/spirometry
IMT—inspiratory muscle training; N—number; %—percent; FEV1—forced expiratory volume in 1 s; FVC—forced vital capacity; PCO2—arterial partial pressure of carbon dioxide;
mmHg—millimeters of mercury; cm H2O—centimeters of water; RT—randomized trial; @—at; X—times; NR—not reported; PImax—maximum inspiratory pressure; min—minutes;
s—second; PT—physical therapist.
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Table 2 Characteristics of studies included in the systematic review: IMT versus no intervention and low intensity IMT versus high intensity IMT.
Study Method Sample size
(N ¼ at
baseline;
W ¼ %
withdrawal)
Patient
characteristics
(mean age in
years; % male
upon
completion of
study)
Severity of
COPD
(FEV1%
predicted
or FEV1/
FVC)
Mode of IMT and
supervision
Monitoring
of breathing
pattern
Time, intensity and
progression of IMT
Frequency
and
duration of
IMT
Outcomes
assessed
Reid and
Warren25
RT; IMT versus
no
intervention
versus
treadmill
N ¼ 12,
W ¼ 0%
66 years, 83%
male
NR Inspiratory
resistance
trainer;
supervised by PT
Monitored
with
metronome
at 16
breaths per
min
30min per session @
unknown intensity.
Increased level of
resistance until able
to tolerate 5min.
1X per day,
5 days per
week for 6
weeks
Inspiratory
muscle
strength,
exercise
capacity,
Pulmonary
function tests/
spirometry
Hsiao et
al.26
RT; Target IMT
versus
Threshold IMT
versus no
intervention
N ¼ 42,
W ¼ 28:6%
70 years, 87%
male
FEV1 51%
predicted
Threshold load
trainer and Target
inspiratory
resistance
trainer; daily log
(home based IMT
program)
Noseclips 15min per session @
50% PImax. Intensity
adjusted every 2
weeks at lab to
ensure intensity
maintained at 50%
PImax.
2X per day,
5 days per
week for 8
weeks
Inspiratory
muscle
strength,
inspiratory
muscle
endurance,
exercise
capacity,
quality of life,
Dyspnea
Preusser
et al.27
RT; Low
intensity
versus high
intensity IMT
N ¼ 22,
W ¼ 9:1%
66 years, 36%
male
FEV1 34%
predicted
Threshold load
trainer;
Supervised
NR 5min (week
1)–18min (week 12)
@ 52% PImax (HIGH)
and @ 22% PImax
(LOW). Intensity
adjusted every 4
weeks to maintain
target intensity.
1X per day,
3 days per
week for 12
weeks
Inspiratory
muscle
strength,
inspiratory
muscle
endurance,
Exercise
capacity
IMT—inspiratory muscle training; N—number; %—percent; FEV1—forced expiratory volume in 1 s; FVC—forced vital capacity; RT—randomized trial; NR ¼ not reported; min–minutes;
@—at; X–times; PImax—maximum inspiratory pressure; PT—physical therapist.
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Table 3 Characteristics of studies included in the systematic review: non-targeted inspiratory resistive IMT versus sham IMT.
Study Method Sample size
(N ¼ at
baseline;
W ¼ %
withdrawal)
Patient
characteristics
(mean age in
years; % male
upon
completion of
study)
Severity of COPD
(FEV1% predicted or
FEV1/FVC)
Mode of IMT and
supervision
Monitoring of
breathing pattern
Time, intensity and
progression of IMT
Frequency and
duration of IMT
Intensity of
sham IMT (cm
H2O)
Outcomes assessed
Bjerre-Jepsen
et al.28
RT; IMT versus
sham
N ¼ 28,
W ¼ NR
62 years, %
male NR
FEV1/FVC ¼ 0.39 Face mask with variable
inspiratory resistance;
Not supervised
Not controlled 15min per session @
unknown intensity
(resistance participants
could not manage to
breathe through for
2min). Intensity
progressed every 2
weeks.
3X per day, 7
days per week
for 6 weeks
No inspiratory
resistance
Exercise capacity
Falk et al.29 RT; IMT versus
sham
N ¼ 27,
W ¼ 0%
64 years, 59%
male
FEV1 29% predicted Inspiratory resistance
trainer; Checked by PT
every 2 weeks to see if
apparatus used correctly
and to increase intensity
NR Up to 10min (2–10min)
per session @ resistance
that participants could
breathe for 2min without
discomfort. Intensity
increased every 2 weeks
as able to tolerate for
2min without discomfort.
3X per day, 7
days per week
for 12 weeks
No inspiratory
resistance
Inspiratory muscle endurance,
Dyspnea, Pulmonary function
tests/spirometry
Guyatt et al.30 RT; IMT versus
sham
N ¼ 133,
W ¼ 38:3%
66 years, 71%
male
FEV1/FVC ¼ 0.40 PFlex inspiratory muscle
trainer; Not supervised.
Training sessions prior to
study with nurse at
weekly intervals
NR 10min per session @
setting on PFlex. Began
at lowest resistance level
and if tolerated, intensity
was increased to next
level each week.
5 X per day, 7
days per week
for 24 weeks
’’
Minimal
resistance’’ (p.
598)
Inspiratory muscle strength,
Inspiratory muscle endurance,
Exercise capacity, quality of
life
Jones et al.31 RT; IMT versus
sham versus
exercise
N ¼ 30,
W ¼ 30:0%
61 years, 57%
male
NR Inspiratory resistance
trainer; watched every 2
weeks at lab
NR 15min per session @
unknown intensity
(resistance that produced
fatigue of breathlessness
after 15min of breathing)
progression of intensity
NR
2X per day, 7
days per week
for 10 weeks
No inspiratory
resistance
Exercise capacity, Dyspnea,
Pulmonary function tests/
spirometry
McKeon et al.32 RT; IMT versus
sham
N ¼ 18,
W ¼ NR
68 years, %
male NR
FEV1 36% predicted Inspiratory resistance
trainer; spouses asked to
supervise and then asked
to sign diary directly
after intervention
Not controlled—
’’
normal
rate’’
15min per
session @
approximately
4-4.5mm
resistance
3X per day, 7
days per week
for 6 weeks
No inspiratory resistance
Inspiratory
muscle
strength,
exercise
capacity
Richardson et
al.33
RT; IMT versus
sham
N ¼ 21,
W ¼ 23:8%
68 years, 81%
male
FEV1 35% predicted Inspiratory resistance
trainer; not supervised
Not controlled
(breathing pattern
not monitored)
30min per session @
unknown intensity.
Intensity increased
depending on resistance
able to tolerate for 5min.
1X per day, 5
days per week
for 6 weeks
’’
Minimal
resistance’’
Inspiratory muscle strength,
Inspiratory muscle endurance
IMT—inspiratory muscle training; N—number; %—percent; FEV1–forced expiratory volume in 1 s; FVC—forced vital capacity; RT—randomized trial; @—at; X–times; NR ¼ not
reported; min—minutes; PT—physical therapist.
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E.L. Geddes et al.1448withdrawal rates among the other studies ranged
from 9% to 51%.6,16,17,19,20,26,27,30,31,33 Seven stu-
dies reported that loss of interest or non-compli-
ance was a reason for withdrawal.6,17,19,20,26,30,31
Other reasons for withdrawal included: pulmo-
nary health problems,6,17,19,20 other ill-
nesses16,19,20,30,31,33 including surgery27 and admis-
sion to hospital,26 work, family or transportation
issues,19,33 homelessness,27 social reasons,31 and
change in medications.26 The remaining 7 of the 19
studies did not report on withdrawal rates.
Fourteen of the 19 included studies reported that
comparison groups were similar at base-
line.6,16–18,26,28–33 Three studies did not report on
group similarity at baseline.19,21,25 Two studies had
older participants,20 participants with lower arter-
ial oxygen,20 or fewer males27 in the sham group.
Intention-to-treat was performed in two of the
19 included studies that reported no drop-outs18,29
and was inferred in 11 of the 19 studies, because
group participants appeared to be analyzed based
on the groups to which they were originally
randomized.16,21–25,27,28,31–33 In the remaining 6
studies, intention-to-treat analysis was not per-
formed, but rather a per protocol analysis was
conducted whereby participants who were non-
compliant with the intervention were excluded
from the analysis.6,17,19,20,26,30Targeted inspiratory resistive or threshold
IMT versus sham IMT
Ten studies compared targeted inspiratory resistive
or threshold IMT versus sham IMT6,16–24 (Table 1).
Five of the ten meta-analyses conducted using
these studies (Table 4) demonstrated a statistically
significant overall effect in favor of targeted
inspiratory resistive IMT or threshold IMT. Inspira-
tory muscle strength, as reflected by PImax,
improved by 12.3 cm H2O (95% CI: 7.5, 17.1,
Po0:00001, n ¼ 233). Inspiratory threshold load-
ing, a measure of inspiratory muscle endurance,
increased by 1.0 kPa (95% CI: 0.3, 1.7, P ¼ 0:005,
n ¼ 74). Exercise capacity measures improved: the
Borg score for respiratory effort decreased by 2.3
points (95% CI: 3.1, 1.5, Po0:00001, n ¼ 40)
and work rate maximum improved by 13.8 watts
(95% CI: 4.2, 23.3, P ¼ 0:005, n ¼ 34). Dyspnea as
indicated by TDI improved by 3.4 points (95% CI:
1.9, 5.0, Po0:00001, n ¼ 59). Of these five meta-
analyses, however, three were statistically signifi-
cant for heterogeneity (PImax, inspiratory threshold
loading, TDI). Two other meta-analyses that did not
show an overall effect (respiratory muscle endur-
ance time, maximum oxygen consumption) werealso statistically significant for heterogeneity. In
these instances, sensitivity analyses were con-
ducted to determine the robustness of findings.
Where applicable, results of the sensitivity analyses
and potential reasons for heterogeneity are dis-
cussed in the comments section in Table 4.
Two of the studies20,23 included outcomes related
to quality of life but a meta-analysis was not
possible since both studies used different mea-
sures. No changes were reported in the Profile of
Mood States, the Health Perceptions Questionnaire
or Sickness Impact Profile20 whereas a large
clinically significant change in the CRQ was re-
ported after IMT23(1.3–1.6 points for each scale
relative to the typical responsiveness estimate of
0.5/7 point change on any CRQ scale).34
Targeted inspiratory resistive or threshold
IMT versus no intervention
A non-significant improvement in PImax was shown
in the meta-analysis comparing targeted inspira-
tory resistive IMT alone versus no intervention
(Table 5), whereas a statistically significant in-
crease in PImax of 14.1 cm H2O was shown by the
meta-analysis that compared targeted inspiratory
resistive or threshold IMT compared to no interven-
tion (95% CI: 1.3, 26.9, P ¼ 0:03, n ¼ 27) (Table 6).
Low IMT versus high IMT
In the one study27 comparing low- versus high-
threshold IMT, both groups showed significant
improvements in the incremental threshold loading
test, inspiratory muscle endurance and the 12MWT.
The high IMT group also showed improvement
in PImax.
Threshold IMT versus targeted inspiratory
resistive IMT
The one study26 that compared threshold to
targeted inspiratory resistive IMT using a home-
based training protocol showed similar significant
improvements in PImax, respiratory muscle endur-
ance time and the 6MWT test for both types of
training.
Non-targeted inspiratory resistive IMT versus
sham IMT
For the six studies comparing non-targeted inspira-
tory resistive IMT versus sham IMT28–33 (Table 3),
only one meta-analysis was possible. Inspiratory
muscle strength (Table 7) as measured by PImax
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E.L. Geddes et al.1454showed a non-significant trend towards an increase
in PImax for participants in the IMT group compared
to participants in the sham group.
Only one of the six studies29 reported significant
differences between the IMT and sham groups
which included decreased dyspnea, decreased
functional residual capacity, decreased respiratory
rate at rest and during exercise, and increased
endurance time on a cycle ergometer with the use
of IMT.
Three studies30–32 concluded that IMT provided
no additional improvement for individuals with
COPD compared to sham IMT and one28 found
improvement in stair-climbing ability in both the
intervention and control groups but concluded that
IMT did not contribute to the improvement ob-
served.
The final study in this grouping33 stated that the
majority of the participants in the study were not
training at a sufficient level because the research-
ers did not control the pressure generation and
breathing pattern during the training sessions.Discussion
This systematic review demonstrated that the
mode of IMT is important in order to achieve a
significant improvement of inspiratory muscle
strength, endurance and exercise capacity in adults
with COPD. Targeted inspiratory resistive or thresh-
old IMTwhen compared with sham IMT significantly
improves some outcomes of inspiratory muscle
strength (PImax), inspiratory muscle endurance
(inspiratory threshold loading) and exercise capa-
city (Borg score for respiratory effort, work rate
maximum), and decreases dyspnea (TDI) (Table 4).
It had no effect on respiratory muscle endurance,
maximal oxygen consumption, 12min walk test,
FVC or FEV1. On the other hand, non-targeted
inspiratory resistive IMTwhen compared with sham
IMTshowed no effect on inspiratory muscle strength
(PImax) (Table 7) and only one of six studies
29 using
non-targeted inspiratory resistive IMT reported
significant outcomes favoring IMT. No conclusions
could be drawn regarding the effect of any mode of
IMT on quality of life outcomes.
In the meta-analyses comparing targeted inspira-
tory resistive or threshold IMT to no intervention,
inspiratory muscle strength (PImax) improved when
either mode (type) of IMT (targeted or threshold)
were included in meta-analysis (Table 6), whereas
there was no improvement in this outcome with
targeted inspiratory resistive IMT alone in meta-
analysis (Table 5). This finding was likely due to the
ARTICLE IN PRESS
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heavier weighting of this study when combining
the studies in the meta-analysis.
Two systematic reviews have been conducted on
this topic previously.7,8 Neither one, however,
stratified the studies based on the mode of IMT
used in the intervention group(s), nor, the type of
intervention used in the control group(s) (e.g.
sham, no intervention). Although Smith et al.7
identified the type (mode) of training, all of the
studies were combined in their meta-analysis and
they did not describe or consider the type of
intervention used in the control groups. This may
explain their conclusion that there is little support
for IMT for individuals with COPD. On the other
hand, Lo¨tters et al.8 addressed the issue of
controlling the training loads by including studies
with training intensities X30% PImax, but again
neither the mode(s) of IMT nor the type of
intervention(s) used in the control groups was
described. Lo¨tters and colleagues concluded
’ ’
that
IMT alone significantly improves inspiratory muscle
strength and endurance, whereas the sensation of
dyspnea significantly decreases.’’8, p. 574
There are several issues to consider when
interpreting the results of our study. Our review is
based on a small number of trials (n ¼ 19), which
involved relatively small numbers of participants
(range of 12–133 participants). Moreover, six of the
meta-analyses combined only two studies. Although
the use of standard mean difference would permit
the inclusion of a greater number of studies with
different outcomes within a meta-analysis, this is
not recommended by the Cochrane Reviewer’s
Handbook9 as this would eliminate the units of
outcome being analyzed, thus making it difficult to
interpret the results for use within clinical prac-
tice. The meta-analyses were also limited due to
differences in the modes of IMTused, and the types
of outcomes assessed within the individual studies.
As a result, meta-analyses could not be performed
for outcomes of HRQL.
Statistical heterogeneity was present in five of
the meta-analyses. Reasons for heterogeneity in
this review may include variance between studies
pertaining to the type of participants, frequency,
intensity, mode and duration of the intervention,
and whether or not the intervention was supervised.
In instances where there was statistical heteroge-
neity, a random effects model was used, sensitivity
analyses performed, and individual studies were
examined to explain heterogeneity and to deter-
mine whether to proceed with the analysis.
Included studies consisted of predominately male
participants (comprising approximately 70% of the
total participants), limiting our ability to interpretresults for females living with COPD. The longest
study lasted for 24 weeks, with an average duration
of 10.5 weeks, which limited our ability to
determine long-term outcomes of IMT for persons
with COPD.
Finally, limitations in this systematic review may
exist because of bias. There is potential for
publication bias, either because only published
studies were included in this systematic review or
because there may be a tendency in the literature
to have more positive studies published in relation
to smaller less significant ones. This may have
resulted in an over-estimation of IMT effect. Funnel
plots, an aid to detecting publication bias, were not
included in this paper since they are difficult to
interpret when combining less than 10 studies.9
There is also potential for observer bias (due to lack
of double-blinding particularly for the assessors of
outcomes, and for those studies that did not include
sham IMT), for migration bias (due to large with-
drawal rates), and for selection bias (differences in
comparison groups at baseline in some studies might
have resulted in confounders being distributed
unevenly between some groups). Withdrawal rates
among included studies ranged from 0% to 51%, with
non-compliance highlighted as being a reason for
withdrawal in many of the included studies (n ¼ 7).
The lack of intention to treat analysis within
individual studies impacts our ability to determine
the effectiveness of IMT versus its efficacy.
The results of this systematic review have
implications for future research. Current research
is limited to individuals with stable COPD and does
not consider whether there may be an optimal time
to prescribe IMT regarding the course of COPD, the
severity of COPD or in relation to acute exacerba-
tions of COPD. Furthermore, it would be important
to confirm the effectiveness of IMT in both genders.
While this systematic review demonstrates positive
effect related to the use of targeted inspiratory
resistive or threshold IMT in people with COPD,
further research is warranted to determine if there
is: an optimal mode of IMT (threshold, targeted
inspiratory resistive or some other combination of
inspiratory resistive and high volume loading); an
optimal training intensity; and if IMT significantly
improves HRQL and other functionally based out-
comes that will have direct implications for both
the person with COPD and health care utilization,
given the dearth of research on the effect of IMT in
these outcomes.
Clinical implications
The inspiratory muscles, like other skeletal mus-
cles, undergo adaptation in response to overload
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changes in muscle strength and endurance as well
as exercise performance. However, for a training
effect to be achieved, the appropriate mode must
be prescribed.36,37 Use of targeted inspiratory
resistive or threshold modes of IMT ensures that
the training intensity is achieved and maintained
during the exercise protocol whereas the non-
targeted inspiratory resistive mode does not.
For a training effect, the frequency, duration and
intensity of exercise must also be considered.
Standard guidelines suggest a training frequency
of 1–2 times per day for a total duration of
20–30min, 3–5 days per week.37 While Ramı´rez-
Sarmiento et al.6 demonstrated functional im-
provement and adaptive cellular changes in the
inspiratory muscles after 5 weeks of training,
training must be maintained for the cellular
training effects to be sustained.38 Recognizing that
in individuals with COPD, the inspiratory muscles
are at risk for fatigue and injury,36,39 Reid et al.40
recommend the following parameters for IMT in
COPD: an initial training interval of as short as
3–5min, progressing to two 15min or one 30min
session(s) per day, 4–6 days per week at a training
intensity of 40–70% PImax indefinitely.
In the subgroup comparison of targeted inspira-
tory resistive or threshold IMT versus sham, most
protocols trained for 30min per day in one or two
sessions6,16–21,23,24 and one study22 trained for
15min four times a day for a total of 60min. The
number of sessions ranged from 5 to 7 days per
week. The training intensity varied from 30% PImax
19–21,23,24 to 60% PImax.
18 However, an intensity of as
low as 22% demonstrated positive results when the
training sessions were supervised.27
When prescribing IMT for individuals with COPD,
the clinician must consider the individual’s co-
morbidities, motivation, level of dyspnea, and
severity of disease. The clinician should choose
training parameters that will improve the strength
and endurance of the inspiratory muscles with the
least amount of risk to the patient.40 We recom-
mend the following guidelines when using IMT in
this population. IMT should be carried out for at
least a total of 30min daily but can be spread over
more than one session per day. Training should
occur at least 5 days per week. While gains may be
measurable after as short as 5 weeks, IMT should
become part of the individual’s routine exercise
program. The minimal training intensity necessary
to obtain training effect is less clear and may
depend on the type of supervision provided. It
could start as low as 22% PImax and be progressed to
as high as 60% PImax using a targeted inspiratory
resistive or threshold trainer.Targeted inspiratory resistive IMT is as effective
as threshold IMT for adults with COPD,26 but the
devices have pros and cons that deserve considera-
tion by clinicians and patients when selecting the
preferred device. Hsiao and colleagues26 found that
the targeted trainer provided visual feedback
enhancing the participant’s motivation and was
less expensive, but it was more difficult to ensure
participants were exercising at their target inten-
sity. On the other hand, they reported that the
threshold trainer provided consistent training in-
tensity, though there could be problems in providing
a precise intensity at pressures less than 9 cm H2O.
Participants found it difficult to keep the threshold
trainer dry and clean in the high-humidity environ-
ment in Taiwan where the study was conducted.
There are two more factors that may deserve
consideration when selecting the mode of IMT to
use. With the threshold trainer, the training
intensity is set on the device. If the person does
not generate a high enough pressure to achieve the
training intensity, the valve does not open and the
person is unable to inspire. With targeted inspira-
tory resistive trainer, the device provides a target.
The person can succeed in meeting the target or
not but, either way, still receives an inspiratory
breath. Secondly, the targeted inspiratory resistive
trainer has a short ramping up and ramping down of
pressure intensity with each inspiration whereas
threshold trainer produces a square waveform with
each inspiration.Conclusion
This systematic review has shown that targeted
inspiratory resistive or threshold IMT significantly
improves inspiratory muscle strength and endur-
ance, and decreases dyspnea for adults with stable
COPD. Since only some outcomes of exercise
capacity were improved with these modes of IMT,
further research is needed. Non-targeted inspira-
tory resistive IMT is not shown to provide any
conclusive benefit. At present, the choice between
using either targeted inspiratory resistive or thresh-
old IMT rests upon clinical considerations. Training
protocols must include sufficient frequency, inten-
sity and duration of IMT and supervision may have
an effect on outcomes.Acknowledgements
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